The boxplot demonstrated that SLPI is down-regulated in prostate cancer patients, while the CENPF, TOP2A and OR51E2 are up-regulated in prostate cancer patients compared with the normal cohort (Figures 7F–I). Here, CENPF is linked to prostate carcinoma.